Anti-SARS-CoV-2, Nucleocapsid (N) (COV19-5164)
Product Specifications
Product Name Alternative
Anti-SARS-CoV-2, Nucleocapsid (N) (COV19-5164)
Clonality
Monoclonal
Components
Concentration: >=1.0 mg/mL; Formulation:Formulated in 0.01 M phosphate buffered saline, pH 7.2 and contains 0.1% sodium azide. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1406157-01 0.02 mg (E-Coli)
Recombinant Glycine max Chalcone--flavonone isomerase 1A (CHI1A)
Ask
View Details MBS1406157-02 0.1 mg (E-Coli)
Recombinant Glycine max Chalcone--flavonone isomerase 1A (CHI1A)
Ask
View Details 
MBS1406157-03 0.02 mg (Yeast)
Recombinant Glycine max Chalcone--flavonone isomerase 1A (CHI1A)
Ask
View Details 
MBS1406157-04 0.1 mg (Yeast)
Recombinant Glycine max Chalcone--flavonone isomerase 1A (CHI1A)
Ask
View Details MBS1406157-05 0.02 mg (Baculovirus)
Recombinant Glycine max Chalcone--flavonone isomerase 1A (CHI1A)
Ask
View Details MBS1406157-06 0.02 mg (Mammalian-Cell)
Recombinant Glycine max Chalcone--flavonone isomerase 1A (CHI1A)
Ask
View Details